4Accepted Aug 3, 7:01 PM ET
reAlpha Tech (AIRE) CFO Thomas J. Kutzman Jr Receives RSU Award
Accepted (ET)
7:01 PM
Aug 3, 2026
Filed
Aug 3, 2026
Documents
1
Size
8.2 KB
Summary
reAlpha Tech (AIRE) CFO Thomas J. Kutzman Jr Receives RSU Award
What Happened
Thomas J. Kutzman Jr, Chief Financial Officer of reAlpha Tech Corp. (AIRE), received a grant of 47,938 restricted stock units (RSUs) on 2026-07-30 (reported as an award, code A). The RSUs were valued using a 10‑day VWAP of $1.4341 (~$68,748 aggregate value). In a separate acquisition-type transaction (code J) on 2026-08-01, he was issued 15,121 shares of common stock as the second installment of deferred merger consideration related to reAlpha’s acquisition of Prevu, Inc.; that payment used a VWAP of $1.4466, totaling approximately $21,874. Together these transactions represent roughly $90.6K of equity granted/issued to the CFO. Both transactions were reported on a Form 4 filed 2026-08-03.
Key Details
- Transaction dates and reported prices:
- 2026-07-30: 47,938 RSUs granted (price reported $0.00; valuation based on 10‑day VWAP $1.4341).
- 2026-08-01: 15,121 shares issued as deferred merger consideration at VWAP $1.4466 (total ≈ $21,874).
- Transaction codes: A (award/grant) for the RSUs; J (other acquisition) for the deferred consideration issuance.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Vesting/tax notes: RSUs are contingent rights to one share each. Vesting: 50% of the RSUs vest 12 months after grant; the remaining 50% vest in four equal quarterly installments over the following 12 months (subject to continued service and Plan terms).
- Filing timeliness: Form 4 filed 2026-08-03; based on transaction dates (7/30 and 8/1) this appears to be filed within the SEC’s two-business-day reporting window.
Context
- The 47,938 RSUs are compensation for services as an executive officer (quarter ended June 30, 2026) under the company’s equity plan and will convert to shares only as they vest.
- The 15,121 shares were issued to satisfy contractual deferred merger consideration from the Prevu acquisition and are not an open-market purchase. Such awards/issuances are routine corporate compensation/transactional events and do not, by themselves, imply personal buying or selling sentiment.